BiotechTubeBiotechTube
Home/MiNK Therapeutics/Sandra Craig
SC

Sandra Craig

Executive Director of Manufacturing

MiNK Therapeutics

Therapeutic Areas

OncologyPulmonary DiseasesImmunology

MiNK Therapeutics Pipeline

DrugIndicationPhase
agenT-797Solid TumorsPhase 1/2
Engineered iNKT Cell Programs (e.g., CAR-iNKT)Precision Oncology TargetsPreclinical

Leadership Team at MiNK Therapeutics

JB
Jennifer Buell, Ph.D.
Chief Executive Officer
DN
Dr. Nils Rudqvist
Senior Director, Research
RS
Robert Stein, M.D., Ph.D.
Scientific Advisor
MH
Manuel Hidalgo, M.D., Ph.D.
Scientific Advisor
ME
Mark Exley, Ph.D.
Scientific Advisor
JG
Jenny Gumperz, Ph.D.
Scientific Advisor
View full MiNK Therapeutics profile